Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 16 | 2023 | 369 | 2.770 |
Why?
|
| Hydroxyurea | 9 | 2016 | 224 | 1.670 |
Why?
|
| Antisickling Agents | 5 | 2013 | 17 | 1.070 |
Why?
|
| Iron | 5 | 2009 | 382 | 0.770 |
Why?
|
| Fetal Hemoglobin | 4 | 2016 | 36 | 0.760 |
Why?
|
| Stroke | 3 | 2023 | 1094 | 0.560 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2024 | 4639 | 0.540 |
Why?
|
| Phosphoglycerate Kinase | 2 | 2006 | 23 | 0.530 |
Why?
|
| Anemia, Hemolytic | 2 | 2006 | 54 | 0.530 |
Why?
|
| Exome | 3 | 2017 | 1252 | 0.500 |
Why?
|
| Mutation, Missense | 3 | 2020 | 1197 | 0.480 |
Why?
|
| Pyrophosphatases | 1 | 2013 | 49 | 0.430 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2007 | 64 | 0.420 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 112 | 0.420 |
Why?
|
| Erythrocytes | 2 | 2021 | 340 | 0.410 |
Why?
|
| Genetic Variation | 5 | 2024 | 2157 | 0.410 |
Why?
|
| Iron Overload | 2 | 2009 | 34 | 0.400 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 2 | 2024 | 78 | 0.400 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2010 | 32 | 0.350 |
Why?
|
| Inflammasomes | 2 | 2022 | 165 | 0.340 |
Why?
|
| Membrane Proteins | 2 | 2013 | 2975 | 0.330 |
Why?
|
| beta-Thalassemia | 1 | 2009 | 33 | 0.330 |
Why?
|
| Caspase 2 | 2 | 2024 | 45 | 0.320 |
Why?
|
| Intestinal Absorption | 2 | 2007 | 223 | 0.310 |
Why?
|
| DNA Damage | 5 | 2024 | 1989 | 0.310 |
Why?
|
| Haplotypes | 3 | 2013 | 909 | 0.300 |
Why?
|
| Genetic Markers | 1 | 2011 | 1077 | 0.300 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 2576 | 0.300 |
Why?
|
| Erythrocyte Transfusion | 1 | 2009 | 211 | 0.290 |
Why?
|
| Hemochromatosis | 1 | 2007 | 39 | 0.280 |
Why?
|
| Amidohydrolases | 1 | 2006 | 24 | 0.280 |
Why?
|
| Pyridoxal Kinase | 1 | 2006 | 4 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 3262 | 0.270 |
Why?
|
| Receptors, Transferrin | 1 | 2006 | 40 | 0.270 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2006 | 67 | 0.260 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 247 | 0.260 |
Why?
|
| Hemolysis | 3 | 2022 | 127 | 0.240 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2004 | 3 | 0.240 |
Why?
|
| Child, Preschool | 13 | 2024 | 17006 | 0.240 |
Why?
|
| Liver | 3 | 2009 | 3124 | 0.230 |
Why?
|
| Child | 16 | 2024 | 30499 | 0.230 |
Why?
|
| Nuclear Proteins | 4 | 2024 | 3472 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 5755 | 0.230 |
Why?
|
| Genomics | 1 | 2014 | 2830 | 0.220 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 2333 | 0.220 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 600 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 4200 | 0.210 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 813 | 0.210 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 445 | 0.190 |
Why?
|
| Caspases, Initiator | 1 | 2021 | 17 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 522 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 550 | 0.190 |
Why?
|
| Mutation | 5 | 2024 | 15941 | 0.190 |
Why?
|
| Adolescent | 13 | 2024 | 32687 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 46 | 0.180 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2020 | 25 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2006 | 1436 | 0.180 |
Why?
|
| Blood Group Antigens | 1 | 2020 | 73 | 0.180 |
Why?
|
| Brain Ischemia | 1 | 2023 | 316 | 0.170 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 27 | 0.170 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2019 | 11 | 0.170 |
Why?
|
| Blood Cells | 1 | 2019 | 130 | 0.160 |
Why?
|
| Hepcidins | 3 | 2007 | 34 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 209 | 0.160 |
Why?
|
| Caspases | 1 | 2021 | 687 | 0.150 |
Why?
|
| Inflammation | 3 | 2022 | 2534 | 0.150 |
Why?
|
| Drug Resistance | 1 | 2020 | 615 | 0.150 |
Why?
|
| Cohort Studies | 4 | 2020 | 9494 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2016 | 2139 | 0.150 |
Why?
|
| Chronic Disease | 3 | 2009 | 1853 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 433 | 0.140 |
Why?
|
| Humans | 32 | 2024 | 271941 | 0.140 |
Why?
|
| Gene Frequency | 3 | 2020 | 1241 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2022 | 1048 | 0.140 |
Why?
|
| Albuminuria | 1 | 2016 | 112 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 566 | 0.130 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 176 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 872 | 0.130 |
Why?
|
| beta-Globins | 2 | 2013 | 6 | 0.130 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2013 | 26 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 2496 | 0.120 |
Why?
|
| Macrophages | 1 | 2021 | 1377 | 0.120 |
Why?
|
| Genotype | 4 | 2024 | 4266 | 0.120 |
Why?
|
| Apoptosis | 2 | 2024 | 7837 | 0.120 |
Why?
|
| Open Reading Frames | 1 | 2014 | 275 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2024 | 7302 | 0.110 |
Why?
|
| Maximum Tolerated Dose | 2 | 2014 | 1323 | 0.110 |
Why?
|
| Transcriptome | 1 | 2022 | 1950 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2013 | 1559 | 0.110 |
Why?
|
| Thrombosis | 1 | 2019 | 755 | 0.110 |
Why?
|
| Male | 15 | 2024 | 128995 | 0.100 |
Why?
|
| Heme | 2 | 2022 | 83 | 0.100 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2011 | 14 | 0.100 |
Why?
|
| Repressor Proteins | 3 | 2016 | 1730 | 0.090 |
Why?
|
| Risk Factors | 4 | 2016 | 18047 | 0.090 |
Why?
|
| Micronucleus Tests | 1 | 2010 | 19 | 0.090 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 298 | 0.090 |
Why?
|
| Infant | 5 | 2024 | 13936 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 267 | 0.090 |
Why?
|
| Brazil | 2 | 2023 | 172 | 0.090 |
Why?
|
| RNA | 2 | 2022 | 1072 | 0.090 |
Why?
|
| Time | 1 | 2010 | 186 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 3512 | 0.080 |
Why?
|
| Female | 14 | 2024 | 149187 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 5105 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2009 | 719 | 0.070 |
Why?
|
| Hemochromatosis Protein | 1 | 2007 | 24 | 0.070 |
Why?
|
| Mice, Inbred AKR | 1 | 2007 | 54 | 0.070 |
Why?
|
| Luminescence | 1 | 2007 | 45 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 201 | 0.070 |
Why?
|
| Endotoxins | 1 | 2007 | 97 | 0.070 |
Why?
|
| Mice | 6 | 2024 | 36054 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 6516 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2009 | 494 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 1100 | 0.070 |
Why?
|
| Spain | 1 | 2006 | 101 | 0.070 |
Why?
|
| Alleles | 3 | 2020 | 2599 | 0.070 |
Why?
|
| Luciferases | 1 | 2007 | 464 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2016 | 5506 | 0.070 |
Why?
|
| Solubility | 1 | 2006 | 251 | 0.060 |
Why?
|
| Retinal Degeneration | 1 | 2006 | 97 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 495 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2006 | 84 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2006 | 355 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 7237 | 0.060 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2004 | 6 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 2365 | 0.060 |
Why?
|
| Protein Folding | 1 | 2006 | 299 | 0.060 |
Why?
|
| Galactosemias | 1 | 2004 | 17 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 7258 | 0.060 |
Why?
|
| Cell Self Renewal | 1 | 2024 | 69 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 2034 | 0.060 |
Why?
|
| Alu Elements | 1 | 2004 | 90 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 5067 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 835 | 0.060 |
Why?
|
| ADAMTS Proteins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2016 | 13402 | 0.050 |
Why?
|
| Animals | 6 | 2024 | 62823 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2012 | 12223 | 0.050 |
Why?
|
| Microfluidics | 1 | 2022 | 32 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 1501 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 591 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2006 | 1168 | 0.050 |
Why?
|
| Adult | 7 | 2023 | 81889 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2021 | 5788 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 115 | 0.050 |
Why?
|
| Alarmins | 1 | 2021 | 9 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2006 | 689 | 0.050 |
Why?
|
| Gene Expression | 1 | 2009 | 3689 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2009 | 5841 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 5187 | 0.040 |
Why?
|
| Base Sequence | 1 | 2006 | 5500 | 0.040 |
Why?
|
| Syndrome | 2 | 2017 | 1405 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 1177 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 680 | 0.040 |
Why?
|
| Platelet Count | 1 | 2020 | 491 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 689 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 2006 | 1055 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 3089 | 0.040 |
Why?
|
| Apolipoprotein L1 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Duffy Blood-Group System | 1 | 2016 | 8 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2016 | 75 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 132 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 1483 | 0.030 |
Why?
|
| Exons | 1 | 2020 | 1388 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2006 | 6489 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2016 | 738 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 2457 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 426 | 0.030 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2013 | 8 | 0.030 |
Why?
|
| alpha-Thalassemia | 1 | 2013 | 11 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 2351 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2013 | 92 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 4195 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33874 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 606 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1159 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 911 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2013 | 105 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8602 | 0.030 |
Why?
|
| Bilirubin | 1 | 2013 | 224 | 0.030 |
Why?
|
| V(D)J Recombination | 1 | 2011 | 9 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 876 | 0.020 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2011 | 64 | 0.020 |
Why?
|
| Young Adult | 2 | 2023 | 22127 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1134 | 0.020 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2009 | 26 | 0.020 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2009 | 42 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2009 | 44 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 65 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 3924 | 0.020 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 82 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 14881 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 307 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 289 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 233 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 2357 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 641 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2009 | 190 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 674 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 2242 | 0.020 |
Why?
|
| Middle Aged | 3 | 2023 | 90427 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2009 | 1718 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 1832 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 2619 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 1397 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 3540 | 0.020 |
Why?
|
| Ireland | 1 | 2004 | 31 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 3166 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 1668 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 1094 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 1912 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 661 | 0.010 |
Why?
|
| Mitochondria | 1 | 2009 | 1314 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 4509 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 1489 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 4371 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 39800 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15269 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 22550 | 0.010 |
Why?
|